Delcath Systems Inc. (NASDAQ: DCTH) Stock Information | RedChip

Delcath Systems Inc. (NASDAQ: DCTH)


$11.2100
-0.2300 ( -1.67% ) 32.0K

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Market Data


Open


$11.2100

Previous close


$11.4400

Volume


32.0K

Market cap


$360.50M

Day range


$11.1750 - $11.6700

52 week range


$3.7000 - $13.3011

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Dec 14, 2023
4 Insider transactions 1 Dec 11, 2023

Latest News